SS-31

SS-31, also known as elamipretide, is a peptide studied for mitochondrial health. Mitochondria are the parts of your cells that help produce energy.

When mitochondria are under stress, damaged, or not working efficiently, the body may experience problems with energy production, recovery, stamina, muscle function, and overall cellular resilience.

In practical terms, SS-31 is studied for helping protect and support the mitochondria, especially the inner mitochondrial membrane where energy production happens. It connects to cellular energy, oxidative stress defense, mitochondrial structure, muscle function, and age-related cellular stress.

This is not a stimulant. It is not like caffeine or pre-workout. SS-31 is studied for helping the cell's energy system function better at the mitochondrial level, supporting cells in protecting their energy-producing machinery and reducing mitochondrial stress.

SS-31, also known as elamipretide, MTP-131, or Bendavia, is a mitochondria-targeted tetrapeptide. It is designed to localize to the inner mitochondrial membrane, where it interacts with cardiolipin, a specialized phospholipid that plays an important role in mitochondrial structure and energy production.

Cardiolipin is essential for the organization and function of the electron transport chain, the mitochondrial system responsible for producing ATP. When cardiolipin is damaged or disrupted, mitochondrial energy production can become less efficient, oxidative stress can increase, and cellular function can decline.

SS-31 is studied because it binds to cardiolipin and may help stabilize the inner mitochondrial membrane. Mitochondrial dysfunction is connected to fatigue, reduced stamina, impaired recovery, increased oxidative stress, muscle weakness, aging-related decline, and disease processes involving energy failure.

Within Cellular Repair & Longevity, SS-31 sits on the mitochondrial protection and energy-resilience side, at the intersection of mitochondrial structure, oxidative stress, ATP production, and cellular resilience.

Research describes SS-31 as a mitochondria-targeting peptide that may reduce mitochondrial reactive oxygen species, support mitochondrial membrane potential, improve mitochondrial respiration, and protect against mitochondrial damage in preclinical models, one of the more direct mitochondrial compounds in the category.

SS-31 has also been studied in aging-related muscle and mitochondrial function research, investigating effects on aged skeletal muscle, mitochondrial energetics, oxidative stress, and physical function. These findings support interest in SS-31 as a mitochondrial resilience compound but do not prove broad anti-aging outcomes in humans.

Preclinical mechanistic evidence is strong: SS-31 reliably binds cardiolipin, supports mitochondrial membrane potential, reduces mitochondrial ROS, and improves bioenergetics across multiple models.

Human clinical relevance is strongest in Barth syndrome, a rare mitochondrial disease. In September 2025, the FDA granted accelerated approval to Forzinity (elamipretide injection) as the first treatment for Barth syndrome, based on improved knee extensor muscle strength. This approval does NOT extend to longevity, bodybuilding, wellness, recovery, or general mitochondrial optimization.

The FDA-approved product is Forzinity, a regulated elamipretide injection for a specific rare-disease population. Research SS-31 products are not approved drugs.

Compounded peptide products are not FDA-approved and may carry risks related to immunogenicity, peptide-related impurities, and inadequate characterization.

SS-31 should be presented as a research peptide outside its approved Barth syndrome indication. Consult a qualified clinician before any use.

SS-31 is a mitochondria-targeted peptide studied for cardiolipin binding, mitochondrial membrane support, mitochondrial structure, oxidative stress reduction, cellular energy production, ATP-related function, muscle energy metabolism, and cellular resilience under mitochondrial stress.

SS-31 is best positioned as a research peptide involved in mitochondrial structure and energy resilience.

Its strongest practical relevance is the study of how cells protect the mitochondria, maintain energy production, reduce mitochondrial oxidative stress, and preserve cellular function under biological pressure.

The most accurate framing is mitochondrial support and cellular energy research, not guaranteed anti-aging, performance enhancement, or general disease treatment.